UBS Group AG - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 90 filers reported holding IRADIMED CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$128,185
-82.1%
2,889
-80.8%
0.00%
Q2 2023$717,914
+137.9%
15,038
+96.1%
0.00%
Q1 2023$301,737
+7.6%
7,668
-22.7%
0.00%
Q4 2022$280,523
+1068.8%
9,916
+1153.6%
0.00%
Q3 2022$24,000
-48.9%
791
-43.2%
0.00%
Q2 2022$47,000
-59.8%
1,393
-46.9%
0.00%
Q1 2022$117,000
+3.5%
2,622
+7.1%
0.00%
Q4 2021$113,0002,448
+81500.0%
0.00%
Q2 2021$0
-100.0%
3
-99.8%
0.00%
Q1 2021$43,000
+65.4%
1,680
+46.9%
0.00%
Q4 2020$26,000
-10.3%
1,144
-15.6%
0.00%
Q3 2020$29,000
-50.8%
1,356
-46.6%
0.00%
Q2 2020$59,000
-40.4%
2,540
-45.3%
0.00%
Q1 2020$99,000
-32.7%
4,644
-26.1%
0.00%
Q4 2019$147,000
+44.1%
6,284
+29.4%
0.00%
Q3 2019$102,000
+17.2%
4,857
+14.3%
0.00%
Q2 2019$87,000
+102.3%
4,251
+180.4%
0.00%
Q1 2019$43,000
+13.2%
1,516
-2.5%
0.00%
Q4 2018$38,000
-44.9%
1,555
-16.8%
0.00%
Q3 2018$69,000
+64.3%
1,868
-7.8%
0.00%
Q2 2018$42,000
+68.0%
2,025
+14.5%
0.00%
Q1 2018$25,000
-3.8%
1,769
+1.6%
0.00%
Q4 2017$26,000
-25.7%
1,741
-57.8%
0.00%
Q2 2017$35,000
+150.0%
4,130
+163.7%
0.00%
Q1 2017$14,000
-46.2%
1,566
-33.8%
0.00%
Q4 2016$26,000
-25.7%
2,364
+15.8%
0.00%
Q3 2016$35,000
+288.9%
2,041
+394.2%
0.00%
Q2 2016$9,000
-98.7%
413
-98.3%
0.00%
Q4 2015$673,000
+4386.7%
24,002
+2269.4%
0.00%
Q1 2015$15,0001,0130.00%
Other shareholders
IRADIMED CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 140,752$3,290,0003.17%
RK Capital 222,914$5,212,0001.95%
Nine Ten Capital Management LLC 130,272$3,046,0000.76%
Parkman Healthcare Partners LLC 93,500$2,186,0000.63%
Ranger Investment Management 244,963$5,727,0000.38%
CADENCE CAPITAL MANAGEMENT LLC 107,043$2,503,0000.27%
ALGERT GLOBAL LLC 29,652$693,0000.21%
Mondrian Investment Partners LTD 163,939$3,833,0000.10%
NAVELLIER & ASSOCIATES INC 20,800$486,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 56,811$1,328,0000.04%
View complete list of IRADIMED CORP shareholders